Comparison of doxorubicin liposome and epirubicin in adjuvant chemotherapy after HER-2 negative breast cancer surgery

ZHOU Zhu-chao, CAO Yu-xue, WU Jian-hua

Fudan University Journal of Medical Sciences ›› 2021, Vol. 48 ›› Issue (02) : 182-187.

PDF(745 KB)
Welcome to visit Fudan University Journal of Medical Sciences, Share:
PDF(745 KB)
Fudan University Journal of Medical Sciences ›› 2021, Vol. 48 ›› Issue (02) : 182-187. DOI: 10.3969/j.issn.1672-8467.2021.02.006
Papers

Comparison of doxorubicin liposome and epirubicin in adjuvant chemotherapy after HER-2 negative breast cancer surgery

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 48(02): 182-187 https://doi.org/10.3969/j.issn.1672-8467.2021.02.006

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(745 KB)

Accesses

Citation

Detail
Sections
Recommended
Total visitors:　 Visitors of today: 　 Now online:
Copyright © Fudan University Journal of Medical Sciences, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd,.

/

〈 〉